论文部分内容阅读
以中药丹参Savia miltiorrhi zai Beg.及红花Carthamus tinctorus L.为原料,提取其有效部分,配制成静脉输液,药理试验表明具有抗血栓形成,增加冠脉流量,对抗脑垂体后叶引起急性心肌缺血性心电图改变,抗缺氧、增强心肌收缩力、并具有镇静、降压等作用。应用于治疗缺血性脑血管疾病100例,治愈率72%,总有效率为100%;治疗冠心病45例,总有效率为93.3%,分别优于低分子右旋糖酐及丹参组。
The traditional Chinese medicine Salvia miltiorrhi zai Beg. and Carthamus tinctorus L. were used as the raw materials to extract the effective part and formulated as an intravenous infusion. Pharmacological tests showed anti-thrombosis, increased coronary flow, and prevention of acute myocardial defects in the posterior pituitary. Blood electrocardiogram changes, anti-hypoxia, increased myocardial contractility, and has a sedative, blood pressure and other effects. For the treatment of 100 cases of ischemic cerebrovascular disease, the cure rate was 72%, the total effective rate was 100%; for the treatment of 45 cases of coronary heart disease, the total effective rate was 93.3%, which was better than the low molecular dextran and Salvia miltiorrhiza group respectively.